The Slovak Competition Authority approves a merger grounded on the acquisition of direct exclusive control in the sector of health care (AGEL SK / Faculty Hospital / Polyclinic Skalica)

MERGERS: AMO SR approved the merger of undertakings AGEL SK a.s. and Faculty Hospital with Polyclinic Skalica, a.s.* On 3 November 2020 the Antimonopoly Office of the Slovak Republic, the Division of Concentrations, (hereafter "the Office") approved a merger grounded in the acquisition of direct exclusive control of the undertaking AGEL SK a.s., Bratislava (hereafter “Agel SK” or “Notifier”) over the undertaking Faculty Hospital with Polyclinic Skalica, a.s., Skalica (hereafter "Skalica Hospital"). The

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Slovak Competition Authority, The Slovak Competition Authority approves a merger grounded on the acquisition of direct exclusive control in the sector of health care (AGEL SK / Faculty Hospital / Polyclinic Skalica), 13 November 2020, e-Competitions November 2020, Art. N° 98127

Visites 32

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues